The abstract is read at the publisher; the summary is JClub's.
A 3-round Delphi consensus of board-certified US dermatologists reached agreement on 40 pseudofolliculitis barbae best-practice statements, while key areas like grading scales and isotretinoin lacked consensus.
- Why it matters: Clinicians need standardized, evidence-informed guidance for diagnosing and managing pseudofolliculitis barbae, but prior recommendations are not consistently defined across diagnostic and treatment domains.
- What they did: The panel developed and tested 40+ consensus statements across diagnostic criteria, behavioral modification, topical and systemic therapies, procedural options, and occupational considerations using a 9-point Likert scale, with consensus set at ≥75% agreement.
- The result: Behavioral hair-removal changes as first-line care, targeted topical/systemic treatments, and procedures such as laser hair removal were supported, but no agreement emerged on a standardized grading scale, oral isotretinoin for refractory disease, superficial chemical peels, or multiblade razors.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.